Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial.
Asger AndersenFarhad WaziriJacob Gammelgaard SchultzSarah HolmboeSøren Warberg BeckerTage JensenHanne Maare SøndergaardKaren Kaae DodtOle MayUlrik Markus MortensenWon Yong KimSøren MellemkjærJens Erik Nielsen-KudskPublished in: BMC pulmonary medicine (2021)
The trial was retrospectively registered at www.clinicaltrials.gov (NCT04283240) February 2nd 2020, https://clinicaltrials.gov/ct2/show/NCT04283240?term=NCT04283240&draw=2&rank=1 .
Keyphrases
- pulmonary embolism
- pulmonary hypertension
- phase iii
- study protocol
- inferior vena cava
- phase ii
- clinical trial
- liver failure
- computed tomography
- preterm infants
- pulmonary arterial hypertension
- respiratory failure
- randomized controlled trial
- open label
- magnetic resonance imaging
- image quality
- contrast enhanced
- drug induced
- positron emission tomography
- intensive care unit
- hepatitis b virus
- aortic dissection
- pet ct
- placebo controlled